Page 443 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 443
ChaPTEr 29 Host Defenses to Fungal Pathogens 423
characterized by high serum IgE, eczema, and CMC. HIES is REFERENCES
caused by mutations in multiple genes, including STAT3, Tyk2,
41
and DOCK8. Patients with STAT3 mutations have impaired 1. Ruping MJ, Vehreschild JJ, Cornely OA. Patients at high risk of
Th17 differentiation, which results in reduced number of Th17 invasive fungal infections: when and how to treat. Drugs 2008;68(14):
1941–62.
42
cells and IL-17 production. Autosomal dominant CMC is caused 2. Azie N, Neofytos D, Pfaller M, et al. The PATH (Prospective Antifungal
by GOF mutations in STAT1, which lead to decreased IL-17, Therapy) Alliance(R) registry and invasive fungal infections: update 2012.
IL-22, and IFN-γ production and defective Th1 and Th17 Diagn Microbiol Infect Dis 2012;73(4):293–300.
responses. 43-45 In contrast, STAT1 deficiencies confer susceptibility 3. Sobel JD. Vulvovaginal candidosis. Lancet 2007;369(9577):1961–71.
to viral and mycobacterial infections. RORC loss-of-function 4. Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal
mutations have also been reported in humans with candidiasis; infections. Sci Transl Med 2012;4(165):165rv13.
RORC isoforms ROR-γ and ROR-γT are critical for T-cell develop- 5. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus
46
ment and function. Thus the absence of IL-17A/-17F–producing amphotericin B for primary therapy of invasive aspergillosis. N Engl J
T cells likely accounts for the candidiasis in these patients. Med 2002;347(6):408–15.
The identification of genes associated with PIDs revealed 6. Garcia-Vidal C, Viasus D, Carratala J. Pathogenesis of invasive fungal
infections. Curr Opin Infect Dis 2013;26(3):270–6.
several important pathways in host immunity to fungal infections. 7. Vazquez JA, Miceli MH, Alangaden G. Invasive fungal infections in
Collectively, genes associated with PIDs highlight the protective transplant recipients. Ther Adv Infect Dis 2013;1(3):85–105.
and critical role of IL-17 signaling against invasive fungal 8. Cornely OA, Gachot B, Akan H, et al. Epidemiology and outcome of
infections. fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of
the European Organization for Research and Treatment of Cancer
(EORTC 65031). Clin Infect Dis 2015;61(3):324–31.
9. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med
ON ThE hOrIZON 2015;373(15):1445–56.
10. van Woerden HC, Gregory C, Brown R, et al. Differences in fungi present
• The study of fungal immunology has led to a fundamental understanding in induced sputum samples from asthma patients and non-atopic
of the role of C-type lectin receptors (CLRs) in immunology. Innate controls: a community based case control study. BMC Infect Dis
immunology plays a critical and nonredundant role in the defense 2013;13:69.
against invasive fungal infections. 11. Weindl G, Wagener J, Schaller M. Epithelial cells and innate antifungal
• When patients lack neutrophils or develop defects in neutrophil function, defense. J Dent Res 2010;89(7):666–75.
only a subset of patients develop invasive fungal infection (e.g., A. 12. Naglik JR, Moyes DL, Wachtler B, et al. Candida albicans interactions
fumigatus infection).
• These observations suggest that genetic defects in the immune system with epithelial cells and mucosal immunity. Microbes Infect
likely contribute to increased risk of infection. 2011;13(12-13):963–76.
• Identification of genetic mutations that are associated with increased 13. Liu Y, Zhao G, Lin J, et al. The role of Syk signaling in antifungal innate
risk of fungal disease may permit the development of genomic risk immunity of human corneal epithelial cells. BMC Ophthalmol
stratification for high-risk patients. 2015;15:55.
• To this end, rational use of antifungal prophylaxis may decrease the 14. Moyes DL, Runglall M, Murciano C, et al. A biphasic innate immune
burden of fungal disease. MAPK response discriminates between the yeast and hyphal forms
of Candida albicans in epithelial cells. Cell Host Microbe 2010;8(3):
225–35.
15. Kim YG, Udayanga KG, Totsuka N, et al. Gut dysbiosis promotes M2
macrophage polarization and allergic airway inflammation via
SUMMARY fungi-induced PGE(2). Cell Host Microbe 2014;15(1):95–102.
16. Nosanchuk JD, Stark RE, Casadevall A. Fungal Melanin: What do We
To date, more than 5 million distinct species of fungi have been Know About Structure? Front Microbiol 2015;6:1463.
identified, but only a few are relevant to human health. Aspergillus 17. Urban CF, Reichard U, Brinkmann V, et al. Neutrophil extracellular traps
and Cryptococcus are ubiquitous in the environment, and their capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol
spores are routinely inhaled by humans; Candida spp. colonize 2006;8(4):668–76.
human skin, mucosae, and GI tract and, under normal conditions, 18. Plato A, Hardison SE, Brown GD. Pattern recognition receptors in
antifungal immunity. Semin Immunopathol 2015;37(2):97–106.
do not cause disease. Normally, the immune system is able to 19. Bourgeois C, Kuchler K. Fungal pathogens-a sweet and sour treat for
clear and/or limit these pathogens, but in immunocompromised toll-like receptors. Front Cell Infect Microbiol 2012;2:142.
individuals, these fungi can cause serious and often life-threatening 20. Khan NS, Kasperkovitz PV, Timmons AK, et al. Dectin-1 Controls TLR9
infections. Using both TLRs and CLRs, the innate immune system Trafficking to Phagosomes Containing beta-1,3 Glucan. J Immunol
plays a critical role in clearing the invading pathogens. Indeed, 2016;196(5):2249–61.
patients with defects in either innate immune cells (e.g., neu- 21. Kasperkovitz PV, Khan NS, Tam JM, et al. Toll-like receptor 9 modulates
tropenia) or signaling through TLRs and CLRs have an increased macrophage antifungal effector function during innate recognition of
risk for diseases caused by invasive fungal organisms. Adaptive Candida albicans and Saccharomyces cerevisiae. Infect Immun
immunity is also critical, as evidenced by patients with advanced 2011;79(12):4858–67.
HIV disease who are at heightened risk for C. neoformans disease. 22. Mansour MK, Tam JM, Khan NS, et al. Dectin-1 activation controls
maturation of beta-1,3-glucan-containing phagosomes. J Biol Chem
In general, Th1 and Th17 responses are protective, whereas Th2 2013;288(22):16043–54.
responses skew the immune response to allergic and hyperactive 23. Ferwerda G, Netea MG, Joosten LA, et al. The role of Toll-like receptors
responses. and C-type lectins for vaccination against Candida albicans. Vaccine
2010;28(3):614–22.
Please check your eBook at https://expertconsult.inkling.com/ 24. Gringhuis SI, den Dunnen J, Litjens M, et al. Dectin-1 directs T helper
for self-assessment questions. See inside cover for registration cell differentiation by controlling noncanonical NF-κB activation through
details. Raf-1 and Syk. Nat Immunol 2009;10(2):203–13.

